Last reviewed · How we verify

NCT06376734: Expedition

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

Recruiting now Phase 2 Last updated 17 February 2026
What this trial tests

Phase 2 trial testing Transcranial magnetic stimulation in Major Depressive Disorder in 180 participants. Currently enrolling.

Timeline
30 January 2025
Primary endpoint
1 June 2029
1 June 2030

Quick facts

Lead sponsorBrigham and Women's Hospital
PhasePhase 2
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment180
Start date30 January 2025
Primary completion1 June 2029
Estimated completion1 June 2030
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Brigham and Women's Hospital

Who can join

Adults 18 to 65, any sex, with Major Depressive Disorder or Obsessive-Compulsive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants will receive Transcranial Magnetic Stimulation (TMS) at a random location in the left prefrontal cortex, excluding sites that are potentially unsafe. Extensive behavioral testing will be conducted to determine which behaviors are modulated by stimulating which circuits.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of focal brain damage on political behaviour across different political ideologies.
    Siddiqi SH, Balters S, Zamboni G, Cohen-Zimerman S, et al · · 2025 · cited 1× · PMID 40117387 · DOI 10.1093/brain/awaf101

Verify or expand the search:

Other trials of Transcranial magnetic stimulation

Trials testing the same drug.

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06376734.